Skip to main content
Livermore
Livermore
ZHEN

Advisory Services Network, LLC

SEC CIK
0001573876
Latest filing
Aug 12, 2026

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Advisory Services Network, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings

Shares (Q2 2026)
17,295
Value
$943.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRSP by Advisory Services Network, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,295$943.3K<0.1%+330+1.9%AddedHolders
Q1 202616,965$807.0K<0.1%+2,121+14.3%AddedHolders
Q4 202514,844$778.4K<0.1%+1,024+7.4%AddedHolders
Q3 202513,820$895.7K<0.1%+350+2.6%AddedHolders
Q2 202513,470$757.8K<0.1%+3,509+35.2%AddedHolders
Q1 20259,961$339.0K<0.1%−96−1.0%ReducedHolders
Q4 202410,057$395.8K<0.1%−7,629−43.1%ReducedHolders
Q3 202417,686$955.2K<0.1%00.0%UnchangedHolders
Q2 202417,686$955.2K<0.1%+112+0.6%AddedHolders
Q1 202417,574$1.20M<0.1%−100−0.6%ReducedHolders
Q4 202317,674$1.11M<0.1%+3,854+27.9%AddedHolders
Q3 202313,820$627.3K<0.1%−706−4.9%ReducedHolders
Q2 202314,526$815.5K<0.1%+170+1.2%AddedHolders
Q1 202314,356$649.3K<0.1%+11,907+486.2%AddedHolders
Q4 20222,449$99.6K<0.1%−635−20.6%ReducedHolders
Q3 20223,084$202.0K<0.1%−3,203−50.9%ReducedHolders
Q2 20226,287$382.0K<0.1%−7,133−53.2%ReducedHolders
Q1 202213,420$842.0K<0.1%+1,069+8.7%AddedHolders
Q4 202112,351$936.0K<0.1%−435−3.4%ReducedHolders
Q3 202112,786$1.43M<0.1%+337+2.7%AddedHolders
Q2 202112,449$2.02M0.1%+2,291+22.6%AddedHolders
Q1 202110,158$1.24M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.